What ICD‑10 code should I use for a knife‑induced cut (open wound) and for administering a Tdap vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Coding for Knife-Induced Laceration and Tdap Administration

ICD-10 Code for the Knife Wound

For a knife-induced open wound, use the appropriate code from the S-series (injury codes) based on the anatomic location of the laceration, combined with an external cause code (W-series) to document the mechanism of injury.

Injury Code Selection (S-series)

  • Select the specific anatomic site code for the open wound (e.g., S61.411A for laceration without foreign body of right hand, initial encounter; S31.011A for laceration without foreign body of lower back and pelvis, initial encounter) 1
  • The seventh character "A" indicates initial encounter for acute injury 1
  • Specify laterality (right/left) and whether a foreign body is present when applicable 2

External Cause Code (W-series)

  • Add W26.1XXA (contact with knife, initial encounter) as the external cause code to document the mechanism of injury 1
  • The "XX" placeholder maintains proper code structure 3
  • This dual-coding approach captures both the injury itself and how it occurred 3

ICD-10 Code for Tdap Administration

Use Z23 (encounter for immunization) as the primary code when the visit is specifically for vaccination.

Vaccination Encounter Coding

  • Z23 is the appropriate code for any encounter where immunization is the primary reason for the visit 1
  • If Tdap is administered during wound management (not as the primary reason for the visit), the wound code takes precedence and Z23 becomes a secondary code 1

Additional Coding Considerations

  • Document the specific vaccine administered using CPT codes (90715 for Tdap) for billing purposes, though this is separate from ICD-10 diagnosis coding 1
  • If the patient has incomplete vaccination history requiring completion of a primary series, consider adding Z28.3 (underimmunization status) as an additional code 1

Clinical Context for Tdap Administration

Tdap is strongly preferred over Td for wound management in adults who have not previously received Tdap or whose Tdap history is unknown, as this provides additional protection against pertussis. 4

Wound Classification and Vaccination Algorithm

  • Knife wounds are classified as contaminated/tetanus-prone wounds because they may be contaminated with dirt, soil, or create conditions favorable for Clostridium tetani growth 1
  • For patients with ≥3 previous tetanus doses and last dose ≥5 years ago: administer Tdap (preferred) or Td WITHOUT tetanus immune globulin (TIG) 4, 1
  • For patients with <3 documented doses or unknown history: administer BOTH Tdap AND TIG 250 units IM at separate anatomic sites using separate syringes 1

Critical Time Intervals

  • Contaminated wounds require booster vaccination if ≥5 years have elapsed since the last dose (not the routine 10-year interval used for clean, minor wounds) 4, 1
  • Patients who received tetanus-containing vaccine <5 years ago do not require additional vaccination for wound management 1

Common Coding Pitfalls to Avoid

  • Do not use "unspecified" codes (e.g., S09.9 for unspecified injury of head) when specific anatomic location is documented—this reduces the utility of injury surveillance data 2
  • Do not confuse the 5-year interval for contaminated wounds with the 10-year interval for clean wounds when determining vaccination needs 1
  • Ensure proper sequencing: the injury code is primary when treating a wound, with Z23 as secondary if vaccination is also provided 1
  • Always verify vaccination history rather than relying on patient recall, as persons with unknown or uncertain histories should be considered unvaccinated 1

References

Guideline

Tetanus Vaccination for Nail Penetration Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Coding the circumstances of injury: ICD-10 a step forward or backwards?

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the appropriate treatment for a 30-year-old male with a 12-day history of intermittent coughing episodes, vomiting, and a whooping sound on inspiration, lacking adult Tdap (tetanus, diphtheria, and pertussis) booster shots?
What vaccinations should be updated for a 54-year-old female patient with diabetes who has not received any vaccinations in the past 10 years?
What pertussis prevention measures should a 64-year-old grandmother take, having received a Tetanus and diphtheria (Td) vaccine in 2016, with a new grandbaby in the household?
Should a patient receive a dose of Adacel (Tdap vaccine) before contact with a newborn?
What is the most recommended vaccination for a pregnant patient in her 20s coming for her first antenatal visit, Tetanus, Diphtheria, and Pertussis (TDAP) vaccine or Influenza vaccine?
What is the likely diagnosis and appropriate work‑up and treatment for a patient with recurrent, stereotyped episodes of nausea, vomiting and watery diarrhea occurring every 3–4 weeks, each lasting less than a day, and a mild transient elevation in liver enzymes?
In a 66‑year‑old woman with suprapubic/bladder tenderness, urinary frequency, urgency, cloudy urine, two negative urinalyses, and a markedly distended bladder on ultrasound with a normal post‑void residual volume (~26 mL), what is the appropriate next diagnostic step and management?
What are the symptoms of tuberculosis?
At what INR threshold should vitamin K be given to a warfarin‑treated patient (≥4.5 if asymptomatic, ≥3.0 if bleeding or high‑risk)?
What is the expected timeline for resolution of mild laryngomalacia in a toddler?
What are the pharmacokinetic and pharmacodynamic interactions and safety considerations when combining Invega Sustenna (paliperidone palmitate) with cariprazine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.